BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:The 2nd mRNA Process Development and Manufacturing Summit retu rns to Boston as the most comprehensive and technical industry dedicated forum\, to address key industry bottlenecks from securing quality startin g materials\, quality by design and automated large-scale manufacturing\, to ultimately reduce costs of mRNA production whilst harmonizing with re gulatory expectations.  \; \;\n\n50+ world-class industry experts including leading mRNA players from Moderna\, BioNTech\, CureVac\, Pfize r and more will take center stage across 3 jam-packed days\, with 3 deep- dive content tracks on research scale\, regulatory  \;and clinical sc ale\, and commercial scale covering key areas from plasmid DNA manufactur ing\, in vitro transcription\, purification and mRNA drug product develop ment to help accelerate your mRNA drugs into the clinic and through to ma rket.  \;\n\nJoin 250+ VPs\, Directors and Heads of Process Developme nt\, Drug Substance\, CMC\, and MSAT at the world's only end-to-end meeti ng enabling scalable\, cost-effective and commercially viable global mRNA production.  \;\n\nURLs:Tickets: \;https://go.evvnt.com/1742633- 2?pid=185Brochure: \;https://go.evvnt.com/1742633-3?pid=185\n\nPrices :Drug Developer Pricing | Conference + Focus Day: USD 5396.00\,Drug Devel oper Pricing | Conference + Workshop Day : USD 5396.00\,Drug Developer Pr icing | Conference Only: USD 3299.00\,Academic Pricing | Conference + Foc us Day: USD 4696.00\,Academic Pricing | Conference + Workshop Day : USD 4 696.00\,Academic Pricing | Conference Only: USD 2899.00\,Standard Pricing | Conference + Focus Day: USD 6396.00\,Standard Pricing | Conference + W orkshop Day : USD 6396.00\,Standard Pricing | Conference Only: USD 3999.0 0\n\nSpeakers: \;Tingting Cui | Associate Director |  \;AstraZene ca\, Hui Zhi | Senior Scientist II | Beam Therapeutics\, Andreas Kuhn | S VP - RNA Biochemistry and Manufacturing |  \;BioNTech SE\, Simon Unth an  \;| Senior Director - RNA Manufacturing Technology Development an d Automation  \;|  \;BioNTech SE\, Anna Ernst | Associate Directo r - DNA Process Development  \;|  \;BioNTech SE\, Lili Belcastro | Senior Principal Scientist | Bristol Myers Squibb\, John Li  \;| Di rector - Drug Substance | Capstan Therapeutics\, Ramin Sabet-Azad | Chemi stry\, Manufacturing and Controls Lead |  \;CEPI\, Monica Dommel | As sociate Director - Regulatory Affairs CMC | CureVac SE\, John Zuris | Dir ector - Editing Technologies | Editas Medicine\, Nicole Ruggiero | Chief Executive Officer | EpiVax Therapeutics\, Xinyue Zhang | Manager  \;G eneLeap | Biotech (Luye Life Science)\, Nethaniah Dorh | Associate Direct or - Bioanalytical Development | GreenLight Biosciences\, Stephen Kaba | Director - mRNA-Based Antigen Design | GreenLight BioSciences\, Derek O'h agan | Senior Advisor - Vaccines Research and Development | GlaxoSmithKli neline\, Danny Crawford  \;| Director - Nucleic Acid Process Sciences  \;| Intellia Therapeutics\, Prakash Koodathingal | Director - RNA T herapeutics Development | Immunomic Therapeutics\, Hang Yuan | CTO and Co -Founder | Innovac Therapeutics\, Burak YILMAZ | Co-Founder and President | Kernal Biologics Inc.\, Harris Makatsoris | Professor - Manufacturing Systems | King's College London\, Richard Braatz | Professor | Massachuse tts Institute of Technology\, Ike James | Head of Technology Transfer | M edicines Patent Pool\, Antonio Grilo | Technology Transfer Expert | Medic ines Patent Pool\, Michael Homsy | Scientist | Merck and Co\, Joshua McNe ely | Senior Scientist - Vaccines Process Development | Merck and Co\, Di pendra Gyawali | Senior Scientist and Team Lead - Process Development | M oderna\, Joseph Schariter |  \;Director - Process Development | Moder na\, Sung-Hye Grieco | VP - Process Development and Program Management | Nutcracker Therapeutics\, Harshal Zope | Director - Manufacturing Science and Technology | Orna Therapeutics\, Bill Grier | Associate Director - D rug Substance and Process Development | Omega Therapeutics\, Lakshmi Khan dke | Senior Program Advisor | The PATH Malaria Vaccine Initiative\, Arav indan Rajendran | Senior Principal Scientist - Group Leader  \;| Pfiz er\, Mohamed ElSayed |  \;EVP and CTO |  \;RVAC Medicines\, Chung hee Lee | Sr. Director | ReCode Therapeutics\, Yimin Hua  \;| Head of Biochemistry and Analytical Development\; mRNA Center of Excellence | Sa nofi\, Hongyue Guo | Principal Scientist | Sanofi\, Sujit Jain  \;| D irector - External Manufacturing | SalioGen Therapeutics\, Craig Martin | Professor | University of Massachusetts Amherst\, Zoltan Kis | Lecturer (Assistant Professor) | University of Sheffield\, Jin Zhou | Executive Di rector - Technical Development\; mRNA and Protein Biologics | Ultragenyx Pharmaceuticals\, Vu Thai  \;| Associate Director - Purification Proc ess Development  \;| Ultragenyx Pharmaceutical Inc\, Vivian Chang | A ssociate Director - Upstream Process Development | Ultragenyx Pharmaceuti cal Inc\, Gautam Sanyal | Principal Consultant | Vaccine Analytics LLC.\, Rajesh Beri | Principal Consultant | Vial 2 Vial Bio Solutions\, Christo pher Cheng | VP Process Development and RNA Technology | Verve Therapeuti cs\, Patrick Arbuthnot | Personal Professor and Director | University of the Witwatersrand\, Yasser Kehail | Business and Product Leader - mRNA CD MO Services | Aldevron\, Aleš Štrancar |  \;Executive Managing Direct or  \;|  \;BIA Separations\, Scott Alderucci | Director - mRNA Pr ocess Development and GMP | Curia Global\, Sudhakar | Voruganti Director | Pfanstiehl Inc\, José Castillo | Chief Executive Officer | Quantoom Bio sciences\n\nTime: \;7:00 am to 4:00 pm\n DTEND:20230928T160000 DTSTAMP:20260512T220333Z DTSTART:20230926T070000 LOCATION:Boston Convention and Exhibition Center\, 415\, Summer Street\, B oston\, Massachusetts\, 02210\, SEQUENCE:0 SUMMARY:The 2nd mRNA Process Development and Manufacturing Summit returns to Boston as the most comprehensive and technical industry dedicated foru m\, to ad... UID:38140892-9314-462b-9cd5-e6b40537d5d2 END:VEVENT END:VCALENDAR